Clinical Trial

Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is evaluate the safety of testosterone replacement therapy in men with newly diagnosed low-risk prostate cancer and hypogonadism on active surveillance.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-12-04; most recent amendment 2026-07-20.
Trial Details
NCT Number NCT07278362
Lead Sponsor University of Miami
Conditions Prostate Cancer, Hypogonadism, Male
Enrollment 35 participants
Start Date 2026-08-31
Primary Completion 2031-05-31 (estimated)
Study Completion 2032-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-22